Guard Patch-Your Health Technology Co., Ltd.
Exhibitor: COMMUNICATION AND BIOLOGIC INTEGRATED CIRCUITS (CBIC) LAB, NCKU
Date: 2022-06-25
Booth No.: S1016
「Your Health Technology Co., Ltd. (Yutech) 」 was spin-off from 「Communication and Biologic Integrated Circuits (CBIC) Lab.」of National Cheng Kung University and founded in 1/5/2019 to improve Human health. Yutech was focused on the development of 「Guard Patch-Intelligent wearable technology with internet-of-thing and platforms」. The mission of Yutech is to build a user-friendly development platform with smart wearable systems, which consists of the biosignal SOC and modules, the user-friendly websites and apps, and the artificial intelligence (AI) system on the edging/cloud. With the wearable platform for wireless bio-signal acquisition, the user can access and monitor his own vital signs anytime and anywhere. The main advantages of this system are real-time monitoring, convenient for wear, and easy to use. There are a series of products relative to「Guard Patch」which are developing in Yutech to realize our dream 「Bioelectronics Garden」in the world.
The products of 「Guard Patch」includes four parts: 1. Medical Market: (1) Guard patch: 24-hour arrhythmia monitoring system (YuGuard), (2) Intelligent medical stethoscope (YuSound), (3) Portable and wireless urine detection system and platform (YuRine). 2. Wearable Market: (1) Smart clothing (YuCloth), (2) Arrhythmia monitoring belt (YuBelt), (3) I-Pet clothing (YuPet). 3. Educative Market: Bio-medical development module for wearable and IOT-based products (TriAnswer). 4. Industrial Market: Customized detection and translation system in factory monitoring (YuCBM). The mentioned products developed by Yutech can be employed in medical, wearable, educative, industrial markets to satisfy the different demands of customers and achieve the dream of 「Bioelectronics Garden」.
More Exhibitor's Press Release
- Third-party Study Report: Investigation of Shear Stress Exerted on Proteins by Different Pump System LEVITRONIX GMBH TAIWAN BRANCH / 2022-08-01
- Third-party Study Report: Investigation of Shear Stress Exerted on CHO Cell by Different Pump System LEVITRONIX GMBH TAIWAN BRANCH / 2022-08-01
- Third-party Study Report: Pump Particle Shedding Evaluation LEVITRONIX GMBH TAIWAN BRANCH / 2022-08-01
- Bio Asia-Taiwan 2022 Opening! Vitae Biomedical showcases the new outstanding achievements. VITAE BIOMEDICAL CO. LTD. / 2022-07-30
- Joint Genomic Analytics Platform from Advantech, GARAOTUS and WASAI GARAOTUS (SYSTEX GROUP) / 2022-07-30
- FDA Grants the Pre-EUA Meeting Request by GoldenBiotech’s Applied Antroquinonol to Treat COVID GOLDEN BIOTECHNOLOGY CORP. / 2022-07-30
- Antroquinonol, Committed to Innovative & Breakthrough Therapy to Improve Quality of Life GOLDEN BIOTECHNOLOGY CORP. / 2022-07-30
- Italy participates for the third time in BIO ASIA with 7 companies ITALIAN ECONOMIC, TRADE AND CULTURAL PROMOTION OFFICE IN TAIPEI TRADE SECTION / 2022-07-29
- AcadeMab makes its mark at 2022 BIO USA ACADEMAB BIOMEDICAL INC. / 2022-07-28
- Taiwan's AcadeMab develops groundbreaking therapy for COVID-19 Omicron variant with potent neutraliz ACADEMAB BIOMEDICAL INC. / 2022-07-28
- Home Visual Acuity tester- Don't let pseudomyopia become real myopia EYEMIKAN BIOTECH INC. / 2022-07-28
- CAMCEVI 42 mg Injection Emulsion Launched in the U.S. for the Treatment of Advanced Prostate Cancer FORESEE PHARMACEUTICALS CO., LTD. / 2022-07-27
- Foresee Announces European MAA Approval of CAMCEVI for the the Treatment of Advanced Prostate Cancer FORESEE PHARMACEUTICALS CO., LTD. / 2022-07-27
- TaiMed is your reliable biologics CDMO partner TAIMED BIOLOGICS INC. / 2022-07-27
- US FDA NDIN approval for Deglusterol, a new dietary ingredient for blood sugar control CAREGEN CO., LTD. / 2022-07-27
- 2022BioAsiaTaiwan-Golden Biotech Seminar Registration_Innovative Breakthrough_COVID-19 to Oncology GOLDEN BIOTECHNOLOGY CORP. / 2022-07-27
- Amaran Biotech Introduces the First Fully-Automated Robotic Aseptic Filling Line in Taiwan AMARAN BIOTECHNOLOGY, INC. / 2022-07-25
- "Montefarmaco’s portfolio covers the main segments of the self-medication market" MONTEFARMACO OTC SPA / 2022-07-22
- TMU BioMed Accelerator | 2022 Batch Demo Day (Register Now) TAIPEI MEDICAL UNIVERSITY / 2022-07-22
- BUCHI wins Swiss Export Award 2022 BUCHI TAIWAN CO., LTD. / 2022-07-21